SCHEMBL29978634

SCHEMBL29978634

O=C(Nc1ccc2c(c1)N(C(=O)c1ccccc1)CCS2)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
GHSR Q92847 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ESR1 P03372 5/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
SHMT2 P34897 1/20 0.40
FAAH O00519 1/20 0.40
AVPR2 P30518 1/20 0.39
AVPR1A P37288 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23768826 1.00 MAPT (0.42) MAPTRAB9ANPC1GHSRKDM4E
SCHEMBL29979338 0.84 FAAH (0.41) MAPTRAB9ANPC1KDM4EESR1
SCHEMBL23769050 0.84 FAAH (0.41) MAPTRAB9ANPC1KDM4EESR1
SCHEMBL30882840 0.82 STING1 (0.51) MAPTRAB9AKDM4EALDH1A1CYP1A2
SCHEMBL25037413 0.82 STING1 (0.51) MAPTRAB9AKDM4EALDH1A1CYP1A2
SCHEMBL23769036 0.82 MAPT (0.56) MAPTKDM4EALDH1A1TP53HTT
SCHEMBL29978853 0.82 MAPT (0.56) MAPTKDM4EALDH1A1TP53HTT
SCHEMBL23769417 0.81 NPC1 (0.50) MAPTRAB9ANPC1KDM4EESR1
SCHEMBL29978840 0.81 NPC1 (0.50) MAPTRAB9ANPC1KDM4EESR1
SCHEMBL23768831 0.78 ESR1 (0.40) MAPTRAB9ANPC1GHSRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 CN claimed
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN claimed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS MAPT 3716/4885RAB9A 719/4885NPC1 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.